Related Experiment Video
Updated: Jun 21, 2025

09:33
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.1K
Diagnostic and Practical Challenges in Applying National Comprehensive Cancer Network Guidelines for Suspected
Daniel I Nathan1, Tehilla Brander2, Julie Gold2
1Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
JCO Precision Oncology
|July 11, 2024
Summary
National Comprehensive Cancer Network (NCCN) guidelines offer benefits but have limitations when differentiating TP53 constitutional mosaicism from Li-Fraumeni syndrome (LFS). Further research is needed for accurate distinction.
Area of Science:
- Oncology
- Genetics
- Clinical Guidelines
Background:
- TP53 gene alterations are crucial in cancer predisposition.
- Distinguishing constitutional TP53 changes from mosaic forms is clinically significant.
- Li-Fraumeni syndrome (LFS) and TP53 constitutional mosaicism (CH) have overlapping features.
Purpose of the Study:
- To evaluate the utility of NCCN guidelines in differentiating TP53 CH from mosaic LFS.
- To identify the benefits and limitations of current guideline-based approaches.
Main Methods:
- Comparative analysis of NCCN guidelines against clinical and genetic data.
- Review of diagnostic criteria and management recommendations.
- Assessment of guideline applicability in complex TP53 alteration cases.
Main Results:
- NCCN guidelines provide a framework but lack specificity for mosaic TP53 alterations.
- Certain criteria may inadvertently group distinct conditions, impacting accurate diagnosis.
- Limitations include challenges in detecting low-level mosaicism and interpreting variant significance.
Conclusions:
- Current NCCN guidelines require refinement to better distinguish TP53 CH from mosaic LFS.
- Improved diagnostic tools and clearer criteria are needed for precise patient management.
- Addressing these limitations will enhance early detection and tailored cancer prevention strategies.

